Cutimed® Siltec® Sorbact® B

is a bacteria and fungi binding wound dressing, based on Sorbact® Technology. It consists of a Sorbact DACC™-coated wound contact layer, combined with an absorbent polyurethane foam that contains superabsorbent stripes and a border with silicone adhesive.

  • Prevents and treats wound infection
  • Safe removal of bacteria, fungi and endotoxins
  • Effective against most common resistant pathogens

Intended Purpose

Cutimed Siltec Sorbact B is intended for use in the management of clean, contaminated, colonised or infected low to high exuding wounds, such as surgical wounds, traumatic wounds, pressure ulcers, diabetic foot ulcers and leg ulcers. It is intended to be used on superficial wounds.

Wear time: Should the clinical condition allow, the dressing can be left in place for up to 7 days.

Product benefits

Symbol of a shield representing infection prevention

Prevents and treats wound infection

Sorbact Technology dressings reduce bioburden and support effective wound healing, with no known contraindications and low risk of allergies1, 2, 3, 4, 5, 6.
Symbol of looped threads to visualize the term 'pacify'

Safe removal of bacteria, fungi and endotoxins

Sorbact Technology dressings irreversibly bind and remove bacteria, without the release of active agents to the wound5. Development of bacterial or fungal resistance is not expected.
Symbol showing crossed out pathogens, which stands for effectiveness against the most common resistant ones

Effective against most common resistant pathogens

In vitro tests show that Sorbact Technology dressings are able to inhibit the growth of the Top 5 World Health Organization (WHO) pathogens7.
Symbol of a hand holding a heart with a feather to visualize that the product is skin-friendly


Skin-friendly silicone adhesive border that minimise trauma and pain for the patient during dressing changes8.
Symbol of a dressing and water droplets that do not reach its backing to visualize the water-repellant feature

Waterproof and breathable backing film

The film provides protection against external contamination and allows excess fluid to evaporate. 

Product facts



Low to high

How to use

Image showing how to apply Cutimed® Siltec® Sorbact B
1. Prepare the wound and surrounding skin according to local clinical practice. Ensure that the surrounding skin is clean and dry.
2. Select an appropriate dressing size and shape that covers the wound and is suitable for the anatomical location. The wound pad should overlap the wound margins. (A) Do not cut the dressing.
3. Remove the dressing from the peel pouch using an aseptic technique.
4. Remove the protective film (B) from the dressing and apply the dressing to the wound. Ensure that the Sorbact wound contact layer comes into direct contact with the complete wound surface to allow microorganisms to bind to the dressing. (C)
5. Avoid stretching the dressing.
6. The dressing change frequency depends on exudate levels and the overall condition of the wound and surrounding skin. Should the clinical condition allow, the dressing can be left in place for up to 7 days.
How to Remove
Gently remove Cutimed Siltec Sorbact B from the wound and discard.

For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s Instructions for Use (IFU).

Product specifications

Essity Product Code
Pack Quantity
PIP Code
Cutimed® Siltec® Sorbact® B 7325100 7.5 cm x 7.5 cm 10 1 ELY505 377-3470
Cutimed® Siltec® Sorbact® B 7325101 12.5 cm x 12.5 cm 10 1 ELY506 377-3488
Cutimed® Siltec® Sorbact® B 7325102 15 cm x 15 cm 10 1 ELY507 377-3504
Cutimed® Siltec® Sorbact® B 7325103 17.5 cm x 17.5 cm 5 1 ELY508 377-3520
Cutimed® Siltec® Sorbact® B 7325104 22.5 cm x 22.5 cm 5 1 ELY509 377-3538

Medical References

1 Bua N et al. Dialkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017;44:387-392.
2 Stanirowski P et al. Randomized controlled trial evaluating dialkylcarbamoyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing cesarean section. Surg Infect (Larchmt). 2016;17:427-435.
3 Kammerlander G et al. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. Wounds UK. 2008;4:10-18.
4 Mosti G et al. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24:121-122, 124-127.
5 Husmark J et al. Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressing: an in vitro study. J Wound Care. 2022;31:560-570.
6 Gentili V et al. Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed Sorbact. Eur J Clin Microbiol Infect Dis. 2012;31:1523-1529.
7 Husmark J et al. Antimicrobial effect of a DACC-coated bacteria-binding wound dressing against WHO pathogens. EWMA. November 18-19, 2020, virtual conference (EP006).
8 Seckam AM et al. Clinical performance and quality of life impact of an absorbent bacteria-binding foam dressing. British Journal of nursing. 2021;30.

Clinical Evidence

On this page, you can view and explore a selection of clinical studies that underline the performance of the Cutimed portfolio.

Discover more

Instruction for use

Please make sure to always follow the instructions for use, including the safety information provided with the product. Not at hand? Find the needed safety information in this database!

Cutimed IFUs